These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6273797)

  • 1. The distribution of benzo(a)pyrene DNA adducts in mammalian chromatin.
    Jack PL; Brookes P
    Nucleic Acids Res; 1981 Nov; 9(21):5533-52. PubMed ID: 6273797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism for the loss of preferential benzo [a] pyrene binding to the linker DNA of chromatin.
    Jack PL; Brookes P
    Carcinogenesis; 1982; 3(3):341-4. PubMed ID: 6282489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential binding of the carcinogen benzo[a]pyrene to DNA in active chromatin and the nuclear matrix.
    Obi FO; Ryan AJ; Billett MA
    Carcinogenesis; 1986 Jun; 7(6):907-13. PubMed ID: 3085969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excision of benzo[a]pyrene diol epoxide I adducts from nucleosomal DNA of confluent normal human fibroblasts.
    Kaneko M; Cerutti PA
    Chem Biol Interact; 1982 Feb; 38(3):261-74. PubMed ID: 6800666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of benzo[alpha]pyrene diol-epoxide with nuclei and isolated chromatin.
    Kootstra A; Slaga TJ; Olins DE
    Chem Biol Interact; 1979 Dec; 28(2-3):225-36. PubMed ID: 121556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
    Tierney B; Benson A; Garner RC
    J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS; Anderson MW
    Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of benzo(a)pyrene and its dihydrodiol-epoxide derivative with nuclear and mitochondrial DNA in C3H10T 1/2 cell cultures.
    Backer JM; Weinstein IB
    Cancer Res; 1982 Jul; 42(7):2764-9. PubMed ID: 6282450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of benzo[a]pyrene to different chromatin domains following activation at the nuclear membrane.
    Obi FO; Billett MA
    Biosci Rep; 1984 Jul; 4(7):541-50. PubMed ID: 6433998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo(a)pyrene 7,8-dihydrodiol-9,10-oxide modification of DNA: relation to chromatin structure and reconstitution.
    Yamasaki H; Roush TW; Weinstein IB
    Chem Biol Interact; 1978 Nov; 23(2):201-13. PubMed ID: 709686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and persistence of DNA, RNA, and protein adducts in mouse skin exposed to pure optical enantiomers of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyre ne in vivo.
    Pelling JC; Slaga TJ; DiGiovanni J
    Cancer Res; 1984 Mar; 44(3):1081-6. PubMed ID: 6198079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential binding of the carcinogen benzo[a]pyrene to proteins of the nuclear matrix.
    Obi FO; Billett MA
    Carcinogenesis; 1991 Mar; 12(3):481-6. PubMed ID: 2009593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting disposition and metabolism of topically applied benzo(a)pyrene, trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in mouse epidermis in vivo.
    Melikian AA; Bagheri K; Hecht SS
    Cancer Res; 1987 Oct; 47(20):5354-60. PubMed ID: 3115566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by aryl hydrocarbon hydroxylase inducers.
    Wilson AG; Kung HC; Boroujerd M; Anderson MW
    Cancer Res; 1981 Sep; 41(9 Pt 1):3453-60. PubMed ID: 6266656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
    Anderson MW; Boroujerdi M; Wilson AG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4309-15. PubMed ID: 6272975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential binding of polycyclic hydrocarbons to matrix-bound DNA in rat-liver nuclei.
    Mironov NM; Grover PL; Sims P
    Carcinogenesis; 1983; 4(2):189-93. PubMed ID: 6297824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect immunofluorescent localization of benzo[a]pyrene adducted to nucleic acids in cultured mouse keratinocyte nuclei.
    Poirier MC; Stanley JR; Beckwith JB; Weinstein IB; Yuspa SH
    Carcinogenesis; 1982; 3(3):345-8. PubMed ID: 6282490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
    Adriaenssens PI; White CM; Anderson MW
    Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of a carcinogen to the nucleosomal and non-nucleosomal regions of the simian virus 40 chromosome in vivo.
    Seidman M; Slor H; Bustin M
    J Biol Chem; 1983 Apr; 258(8):5215-20. PubMed ID: 6300121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.